05 Feb BBA Presenting on the Optimal Approach to Clinical Evaluation Process
President and CEO of BBA Israel, Tami Abudi will present on the Optimal Approach to Clinical Evaluation Reports. She will review how the clinical evaluation process has changed over time, understanding the requirements and placing them into practice and discuss case examples from product development, Pre-CE marking and updates during the post-market phase. This presentation was given at the Arena Outsourcing in Clinical Trials – March 21-21, in Tel Aviv, Israel.
To view the full program details you may download a PDF of the presentation.
If you would like more information about work that BBA is currently doing with the FDA in the EFS program, contact us at firstname.lastname@example.org.